An open-label phase II study evaluating the safety and efficacy of ramucirumab combined with mFOLFOX-6 as first-line therapy for metastatic colorectal cancer

1. Garcia-Carbonero, R.
2. Rivera, F.
3. Maurel, J.
4. Ayoub, J.-P.M.
5. Moore, M.J.
6. Cervantes, A.
7. Asmis, T.R.
8. Schwartz, J.D.
9. Nasroulah, F.
10. Ballal, S.
11. Tabernero, J.